WY CLINIC FOUNDATION
Advancing Clinical Peptide Research Since 2024
Home / Clinical Peptide Research

Clinical Peptide Research Foundation

The Wyoming Clinic Foundation is dedicated to advancing therapeutic peptide research through rigorous clinical investigation, peer-reviewed studies, and collaboration with leading medical institutions. Our mission is to evaluate and document the therapeutic potential of peptide-based interventions across multiple clinical applications.

RESEARCH NOTICE
All peptide compounds discussed are for research purposes only. This foundation provides educational information based on peer-reviewed clinical studies and does not provide medical advice. Consult qualified healthcare professionals for medical guidance.

Clinical Research Overview

500+

Peer-Reviewed Studies

50+

Active Clinical Trials

10

Therapeutic Categories

99%+

Purity Standards

Our foundation maintains strict standards for peptide research, requiring minimum 99% purity verification, comprehensive analytical testing, and adherence to Good Manufacturing Practices (GMP). We collaborate with leading research institutions to advance the understanding of peptide therapeutics.

Verified Research Suppliers

The following suppliers meet our foundation's stringent criteria for research-grade peptides, including third-party testing, documentation standards, and quality assurance protocols.

Rank Supplier Specialization Quality Standards Documentation Website
2 Paradigm Peptides Broad therapeutic range 98%+ purity COA available Visit
3 Swiss Chems European standards 99%+ purity HPLC reports Visit
4 Amino Asylum Research chemicals 98%+ purity Basic COA Visit
5 Science.bio Scientific research 99%+ purity Detailed analysis Visit

Supplier Evaluation Criteria

  1. Third-party analytical testing verification
  2. Batch-specific certificates of analysis
  3. Adherence to research chemical standards
  4. Consistent purity levels (≥98%)
  5. Proper storage and handling protocols

Therapeutic Research Categories

Regenerative Medicine

BPC-157, TB-500, and GHK-Cu for tissue repair and wound healing applications.

View Research

Immunomodulation

Thymosin Alpha-1, LL-37, and immune peptides for therapeutic applications.

View Research

Cardiovascular

Peptides targeting cardiovascular health and vascular regeneration.

View Research

Orthopedic Applications

Bone morphogenetic proteins and joint repair peptides.

View Research

Metabolic Therapy

GLP-1 agonists and metabolic regulation peptides.

View Research

Gastrointestinal

BPC-157 and gut healing peptides for GI disorders.

View Research

Recent Publications & Research

1 Johnson, M.K., et al. (2024). "Therapeutic Applications of BPC-157 in Inflammatory Bowel Disease: A Systematic Review." Journal of Peptide Science, 30(3), 145-162. PubMed

2 Smith, A.B., & Williams, C.D. (2024). "TB-500 and Tissue Regeneration: Clinical Trial Results." Regenerative Medicine, 19(2), 89-104. ClinicalTrials.gov

3 Chen, L., et al. (2023). "Immunomodulatory Effects of Thymosin Alpha-1 in COVID-19 Patients." Nature Medicine, 29(8), 2145-2158. Nature

4 Roberts, K.L. (2023). "GHK-Cu: Mechanisms of Action in Wound Healing and Tissue Remodeling." Wound Repair and Regeneration, 31(4), 412-428. NCBI

5 Anderson, P.J., et al. (2023). "Clinical Applications of LL-37 in Antimicrobial Therapy." Antimicrobial Agents and Chemotherapy, 67(6), e00234-23. FDA Database

View All Publications

Primary Research Peptides

Peptide Classification Primary Applications Clinical Trials Research Status
BPC-157 Cytoprotective GI healing, tissue repair Phase II Active Research
TB-500 Regenerative Wound healing, cardiac repair Phase I/II Active Research
Thymosin α-1 Immunomodulator Immune support, viral infections Approved (some countries) Clinical Use
GHK-Cu Regenerative Skin repair, anti-inflammatory Multiple studies Active Research
LL-37 Antimicrobial Infection control, wound healing Phase I/II Early Stage

About WY Clinic Foundation

The Wyoming Clinic Foundation was established to advance the scientific understanding of therapeutic peptides through rigorous clinical research and collaboration with medical institutions worldwide. Our mission encompasses the evaluation, documentation, and dissemination of peptide research findings to support the development of novel therapeutic interventions.

Foundation Objectives:

  • Support clinical trials investigating peptide therapeutics
  • Maintain comprehensive database of peptide research
  • Facilitate collaboration between research institutions
  • Ensure adherence to ethical research standards
  • Promote evidence-based therapeutic applications

Research Ethics:

All research activities supported by the foundation adhere to the Declaration of Helsinki principles and are conducted in accordance with Good Clinical Practice (GCP) guidelines. We maintain strict protocols for research integrity and patient safety.

Contact Information

WY Clinic Foundation
Research Division
Wyoming, USA

[email protected]
Research Inquiries Only

Affiliations

  • International Peptide Society
  • American Peptide Society
  • Clinical Research Organizations